Inspiratory muscle training for patients with Parkinson's disease
Investigation of the Effects of Inspiratory Muscle Training on Oxygen Consumption, Muscle Oxygen and Physical Activity Level in Patients With Parkinson's Disease
This study is testing if breathing exercises can help improve lung strength and overall function in people with Parkinson's disease.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 45 Years to 80 Years |
| Sex | All |
| Sponsor | Gazi University Academic / other |
| Locations | 1 site (Ankara) |
| Trial ID | NCT06017336 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of inspiratory muscle training on patients with Parkinson's disease, who often experience decreased respiratory muscle strength and function. The research aims to determine whether this training can improve respiratory function and other functional outcomes in these patients. Participants will be divided into an inspiratory muscle training group and a control group that performs breathing exercises. The study will include patients aged 45-80 with a diagnosis of Parkinson's disease for over six months, focusing on those in stages I-III of the disease.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 45-80 with a diagnosis of Parkinson's disease for more than six months and independent walking ability.
Not a fit: Patients with other neurological diseases, significant lung disease, or severe cognitive impairment may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could enhance respiratory function and overall physical capacity in patients with Parkinson's disease.
How similar studies have performed: While inspiratory muscle training has shown promise in improving respiratory strength in other populations, its specific effectiveness in Parkinson's disease remains to be fully established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Between the ages of 45-80, 2. Follow-up with a diagnosis of Parkinson's disease for more than six months 3. Stages I-III according to the modified Hoehn and Yahr scale 4. Parkinson's patients with independent walking capacity will be included. Exclusion Criteria: 1. Having a neurological disease other than Parkinson's disease 2. Patients with a diagnosed lung disease that may affect respiratory functions 3. At least 10 pack years or more of smoking history 4. According to the American Association of Sports Medicine (ACSM) with absolute and relative contraindications to exercise tests 5. Those with a Mini-Mental State Rating Scale score of less than 18 6. Patients with additional cardiac orthopaedic and psychological problems that limit the evaluation will be excluded from the study.
Where this trial is running
Ankara
- Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Clinic — Ankara, Turkey (Recruiting)
Study contacts
- Principal investigator: Musa GÜNEŞ, MsC — Gazi University
- Study coordinator: Meral BOŞNAK GÜÇLÜ, Prof. Dr.
- Email: meralbosnak@gazi.edu.tr
- Phone: +903122162647
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.